Zacks Company Profile for GSK PLC Sponsored ADR (GSK : NYSE) |
|
|
|
Company Description |
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Number of Employees: 68,629 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $38.48 |
Daily Weekly Monthly
 |
20 Day Moving Average: 4,644,860 shares |
Shares Outstanding: 2,047.35 (millions) |
Market Capitalization: $78,781.91 (millions) |
Beta: 0.50 |
52 Week High: $44.67 |
52 Week Low: $31.72 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-6.83% |
-9.62% |
12 Week |
7.85% |
-6.51% |
Year To Date |
13.78% |
7.49% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Dame Emma Walmsley - Chief Executive Officer
Jonathan Symonds - Chairman
Julie Brown - Chief Financial Officer
Charles Bancroft - Director
Hal Barron - Director
|
|
Peer Information
GSK PLC Sponsored ADR (CORR.)
GSK PLC Sponsored ADR (RSPI)
GSK PLC Sponsored ADR (CGXP)
GSK PLC Sponsored ADR (BGEN)
GSK PLC Sponsored ADR (GTBP)
GSK PLC Sponsored ADR (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 37733W204
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/30/25
|
|
Share - Related Items
Shares Outstanding: 2,047.35
Most Recent Split Date: 7.00 (0.80:1)
Beta: 0.50
Market Capitalization: $78,781.91 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 4.38% |
Current Fiscal Quarter EPS Consensus Estimate: $1.31 |
Indicated Annual Dividend: $1.69 |
Current Fiscal Year EPS Consensus Estimate: $4.41 |
Payout Ratio: 0.39 |
Number of Estimates in the Fiscal Year Consensus: 5.00 |
Change In Payout Ratio: -0.11 |
Estmated Long-Term EPS Growth Rate: 5.65% |
Last Dividend Paid: 05/16/2025 - $0.42 |
Next EPS Report Date: 07/30/25 |
|
|
|
|